Role of pharmacist during the COVID-19 pandemic: A scoping review

  1. Marília Berlofa Visacri
  2. Isabel Vitória Figueiredo
  3. Tácio de Mendonça Lima

Reviewed by

Read the full article See related articles

Listed in

Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1016/j.sapharm.2020.07.003
  2. ScreenIT

    SciScore for 10.1101/2020.06.30.20143859: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board Statementnot detected.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.

    Table 2: Resources

    Software and Algorithms
    SentencesResources
    Search strategy: A comprehensive literature search was performed in the MEDLINE (PubMed), Embase, Scopus, and LILACS (Latin American and Caribbean Health Sciences Literature) databases published between December 1st, 2019 (first reports of COVID-19 in China) and May 20th, 2020 in order to identify relevant studies.
    MEDLINE
    suggested: (MEDLINE, RRID:SCR_002185)
    Embase
    suggested: (EMBASE, RRID:SCR_001650)
    18 The authors independently completed the data extraction, using a preformatted spreadsheet in Microsoft Excel.
    Microsoft Excel
    suggested: (Microsoft Excel, RRID:SCR_016137)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).

    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    Limitations: This study has some limitations. It is possible that some studies were missed due to not being indexed in the databases searched or being published in websites of institutions or scientific societies. Moreover, the number of publications on COVID-19 is rapidly increasing in a short time and some studies of interest available after the established search period have not been included. Finally, this review did not analyze the quality of the studies taking into account the inherent characteristic of the scoping reviews.

    Results from TrialIdentifier: No clinical trial numbers were referenced.

    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.

    Results from JetFighter: We did not find any issues relating to colormaps.

    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.

  3. Version published to 10.1101/2020.06.30.20143859v1 on medRxiv